Zevia Lifts 2026 Sales Outlook as Q3 Revenue Climbs 18.4% to $48.3M
ZVIA is trading near its 52-week low of $1.11 (8.1% above the low).
Summary
Zevia posted Q3 net sales of $48.3M, up 18.4% from $40.8M a year earlier, and raised its full-year 2026 sales outlook to $177M-$179M. The release does not state the prior range, so the size of the raise is unclear. The GAAP net loss narrowed to $2.2M from $2.8M, and management now guides 2026 Adjusted EBITDA to breakeven to a $0.4M loss — close to adjusted profitability. Balance sheet is clean: $29.5M cash, no debt, and a $20M facility still undrawn. This follows the Oct. 22 agreement for a $20M convertible preferred investment from a GP Investments fund, which adds capital but also dilution — GP reported a 16.1% as-converted stake on Oct. 29. For a company this small, the swing toward breakeven EBITDA and the raised top-line guide are the numbers that matter; the missing prior outlook range blunts how much credit the raise deserves.
At the time of this announcement, ZVIA was trading at $1.20 on NYSE in the Trade & Services sector, with a market capitalization of approximately $92.8M. The 52-week trading range was $1.11 to $2.78. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.